Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Martin Tobi
Mijin Kim
Douglas H. Weinstein
Mary Ann Rambus
James Hatfield
N. Volkan Adsay
Edi Levi
Douglas Evans
Michael J. Lawson
Suzanne Fligiel
机构：
[1] Philadelphia Veterans Affairs Medical Center,Gastroenterology Section
[2] University of Pennsylvania School of Medicine,Division of Gastroenterology, Department of Medicine
[3] Wayne State University School of Medicine,Department of Medicine and Pathology, John D. Dingell Veterans Affairs Medical Center
[4] M.D. Anderson Cancer Center,Kaiser Permanente
[5] University of California,undefined
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Pancreatic ductal adenocarcinoma (PDA); Adnab-9 monoclonal antibody; K-; Her-2/;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：744 / 750
页数：6
相关论文
共 50 条
  • [21] Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
    Laghi, Luigi
    Beghelli, Stefania
    Spinelli, Antonino
    Bianchi, Paolo
    Basso, Gianluca
    Di Caro, Giuseppe
    Brecht, Anna
    Celesti, Giuseppe
    Turri, Giona
    Bersani, Samantha
    Schumacher, Guido
    Roecken, Christoph
    Graentzdoerffer, Ilona
    Roncalli, Massimo
    Zerbi, Alessandro
    Neuhaus, Peter
    Bassi, Claudio
    Montorsi, Marco
    Scarpa, Aldo
    Malesci, Alberto
    PLOS ONE, 2012, 7 (09):
  • [22] Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma
    Klatte, Derk C. F.
    Weston, Alexander
    Ma, Yaohua
    Sledge, Hanna
    Bali, Aman
    Bolan, Candice
    Engels, Megan
    van Hooft, Jeanin E.
    van Leerdam, Monique E.
    Ouni, Ahmed
    Wallace, Michael B.
    Bi, Yan
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (09) : 1830 - 1838
  • [23] GENOMIC PROFILING OF PANCREATIC DUCTAL ADENOCARCINOMA WITH EXCELLENT PROGNOSIS
    Na, Jieun
    Na, Ji Eun
    Oh, Joo Hyun
    Choi, Kyu
    Park, Jae Keun
    Park, Joo Kyung
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Lee, Kyu Taek
    GASTROENTEROLOGY, 2019, 156 (06) : S329 - S329
  • [24] Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
    Saukkonen, Kapo
    Hagstrom, Jaana
    Mustonen, Harri
    Juuti, Anne
    Nordling, Stig
    Fermer, Christian
    Nilsson, Olle
    Seppanen, Hanna
    Haglund, Caj
    PLOS ONE, 2015, 10 (06):
  • [25] Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients
    Wong, T
    Howes, N
    Threadgold, J
    Smart, HL
    Lombard, MG
    Gilmore, I
    Sutton, R
    Greenhalf, W
    Ellis, I
    Neoptolemos, JP
    PANCREATOLOGY, 2001, 1 (05) : 486 - 509
  • [26] State of the Art Diagnosis of Pancreatic Ductal Adenocarcinoma
    Scharwächter C.
    Haage P.
    Current Radiology Reports, 5 (8)
  • [27] Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma
    Balci, NC
    Semelka, RC
    EUROPEAN JOURNAL OF RADIOLOGY, 2001, 38 (02) : 105 - 112
  • [28] Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Kim, Hongbeom
    Kang, Kyung Nam
    Shin, Yong Sung
    Byun, Yoonhyeong
    Han, Youngmin
    Kwon, Wooil
    Kim, Chul Woo
    Jang, Jin-Young
    CANCERS, 2020, 12 (06)
  • [29] Circulating tumor DNA methylation as markers for early detection of pancreatic ductal adenocarcinoma (PDAC).
    Liu Xiaoding
    Guo Shiwei
    Ma Chengcheng
    Li Yatong
    Liu Xiaoqian
    Zhang Zhiwen
    Yu Lianyuan
    Dai Menghua
    Shen Shuo
    Wu, Huanwen M.
    Su Zhixi
    He Qiye
    Liu Rui
    Gang Jin
    Liang Zhiyong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [30] Circulating tumour DNA methylation are markers for early detection of pancreatic ductal adenocarcinoma (PDAC)
    Liu, X.
    He, Q.
    Liang, Z.
    Wu, H.
    Li, Y.
    Zhang, Z.
    Yu, L.
    Dai, M.
    Guo, S.
    Jin, G.
    Shen, S.
    Su, Z.
    Ma, C.
    Xie, Z.
    Liu, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1289 - S1289
12345